SteadyMed Granted Additional U.S. Patent With Patent Term Extension
April 22, 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 22, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY) a specialty pharmaceutical company, today announced the issuance of a new patent from the United States Patent and...
SteadyMed Appoints David W. Nassif as Its Full Time Executive Vice President and Chief Financial Officer
April 08, 2015 07:30 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company, today announced the appointment of David W. Nassif as its full time Executive...
SteadyMed Announces Pricing of Initial Public Offering
March 20, 2015 07:00 ET
|
SteadyMed Therapeutics
SAN RAMON, Calif., March 20, 2015 (GLOBE NEWSWIRE) -- SteadyMed Ltd., a specialty pharmaceutical company, today announced the pricing of its initial public offering of 4,700,000 ordinary shares at a...